Editorial Board

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Our editorial board is comprised of cancer experts, organized primarily by disease focus. If you are interested in getting involved, please feel free to contact us with any questions or inquiries, at contact @ hemonc.org.

Editor-in-Chief

PeterYang.jpg
Peter C. Yang, MD
Boston, MA, USA
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts.

Deputy Editor

Warner, Jeremy MD 2022.jpg
Jeremy L. Warner, MD, MS, FAMIA, FASCO
Brown University
Providence, RI, USA

LinkedIn
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Lifespan Cancer Institute. He is a Professor of Medicine at Brown University. He is the Director of the Brown/Lifespan Center for Clinical Cancer Informatics and Data Science (CCIDS).

Associate Editors

Cancer Registries
Mesnard M.jpeg
Mary Mesnard, BS, CTR
LinkedIn
Ms. Mesnard is a senior study director at Westat and was formerly with the State of Maryland's central cancer registry.
Evidence-based Oncology
MartinSchoen.jpg
Martin W. Schoen, MD, MPH
Saint Louis University
St. Louis, MO, USA
Dr. Schoen is board certified in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at Saint Louis University.
Pediatric Hematology/Oncology
Liang.jpg
Wayne H. Liang, MD, MS, FAMIA
Emory University
Atlanta, GA, USA

LinkedIn
Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University.
Radiation Oncology
Bitterman.jpeg
Danielle S. Bitterman, MD
Dana-Farber Cancer Institute
Boston, MA, USA

LinkedIn
Dr. Bitterman is board certified in Radiation Oncology; she practices at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School.
Supportive Oncology
Lustberg.jpeg
Maryam B. Lustberg, MD, MPH
Yale University
New Haven, CT, USA

LinkedIn
Dr. Lustberg is board certified in Medicine and Medical Oncology; she is the director of the Breast Center at Smilow Cancer Hospital and chief of Breast Medical Oncology at Yale Cancer Center. She is an Associate Professor of Internal Medicine (Medical Oncology) at Yale University. She is the co-chair of Symptom Intervention Committee for Alliance Clinical Trials, and the 2022 president of the Multinational Association of Cancer Supportive Care (MASCC)

Regional Associate Editors

Asia
Europe and United Kingdom
Lythgoe.jpeg
Mark P. Lythgoe, MBBS, PharmD
Imperial College London
London, England, UK

LinkedIn
Dr. Lythgoe is a medical oncologist, clinical pharmacist, and health services researcher. His work involves analyzing cancer drug approvals and regulatory pathways.
North Africa and Middle East
Oceania
Kennedy.jpeg
Georgina Kennedy, PhD
Ingham Institute for Applied Medical Research
Sydney, NSW, Australia

LinkedIn
Dr. Kennedy is a health data infrastructure specialist and data engineer. Her work involves harmonizing systemic anticancer therapy standards, including the eviQ resource of evidence-based, consensus driven cancer treatment protocols.
Latin America
Sub-Saharan Africa

Section Editors

Breast Oncology
Fernandes Hermina WEB160x200.jpg
H. Deepika Fernandes, MD, FACP
Tempe, AZ, USA
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the HonorHealth Virginia G. Piper Cancer Care Network.
Dermatologic Oncology
Bethbuchbinder.jpg
Elizabeth Buchbinder, MD
Boston, MA, USA

LinkedIn
Dr. Buchbinder is board certified in Medical Oncology; she is a senior physician at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School.
Endocrine Oncology
Unfilled If you are interested in this role, please contact us at contact @ hemonc.org.
Gastrointestinal Oncology, Intestinal
Traviszack.jpeg
Travis Zack MD, PhD
San Francisco, CA, USA
Dr. Zack is a senior hematology/oncology fellow at the University of California, San Francisco.
Gastrointestinal Oncology, Extraintestinal
Eric Marks Headshot.jpg
Eric I. Marks, MD
Boston, MA, USA
Dr. Marks is board certified in Medical Oncology; he practices at Boston Medical Center and is an Assistant Professor of Medicine at Boston University School of Medicine.
Genitourinary Oncology
Alikhaki.jpg
Ali Raza Khaki, MD
Palo Alto, CA, USA
Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at Stanford Health Care. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine.
Gynecologic Oncology
Brown-alaina.jpeg
Alaina J. Brown, MD, MPH
Nashville, TN, USA
Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at the Vanderbilt-Ingram Cancer Center. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University.
Head & Neck Cancer
Choe.jpeg
Jennifer H. Choe, MD, PhD
Nashville, TN, USA

LinkedIn
Dr. Choe is board certified in Internal Medicine and Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center, where she is the Head and Neck Medical Oncology Disease Team Lead and directs the clinical trials research program in the Division of Hematology and Oncology within the Department of Medicine at Vanderbilt University Medical Center. She is an Assistant Professor of Medicine at Vanderbilt University and specializes in cancers of the head and neck, thyroid, and non-melanoma skin cancers.
Mesothelioma
Zauderer-majorie.jpeg
Marjorie G. Zauderer, MD, MS, FACP
New York, NY, USA
Dr. Zauderer is board certified in Medical Oncology; she is co-director of the mesothelioma program at Memorial Sloan Kettering Cancer Center.
Neuro-Oncology
SeemaNagpal.jpg
Seema Nagpal, MD
Palo Alto, CA, USA
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a Clinical Professor of Neurology at Stanford University
Sarcoma
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Nashville, TN, USA
Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center and is the medical director of the Clinical Trials Office. She is an associate professor at Vanderbilt University.
Thoracic Oncology
Amit Kulkarni.jpg
Amit Kulkarni, MBBS
University of Minnesota
Minneapolis, MN, USA
Dr. Kulkarni is board certified in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the University of Minnesota.
Acute Leukemias
AK.JPG
Ashwin Kishtagari, MD
Vanderbilt University
Nashville, TN, USA
Dr. Kishtagari is board certified in Internal Medicine and Medical Oncology; he practices at Vanderbilt University Medical Center. He is an Assistant Professor of Medicine (Hematology/Oncology) at Vanderbilt University.
Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Sanjay mohan.png
Sanjay R. Mohan, MD, MSCI
Nashville, TN, USA
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Aggressive Lymphomas & Lymphoproliferative disorders
TarsheenSethi.jpg
Tarsheen K. Sethi, MD, MSCI
Yale University
New Haven, CT, USA
Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at Yale University.
Indolent Lymphomas
Sanjaisharma.jpg
Sanjai Sharma, MD
Visalia, CA, USA
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center.
Plasma Cell Dyscrasias
Headshot Cowan.jpg
Andrew J. Cowan, MD
Seattle, WA, USA

LinkedIn
Dr. Cowan is board certified in Hematology and Medical Oncology; he is the Interim Clinical Director of the myeloma service at the Fred Hutch Cancer Center. He is an associate professor at the University of Washington.
T-cell and NK-cell neoplasms
Bdholaria.jpg
Bhagirathbhai Dholaria, MBBS
Nashville, TN, USA
Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.
Histiocytic Disorders
GauravGoyal.jpg
Gaurav Goyal, MBBS
UAB
Birmingham, AL, USA
Dr. Goyal is board certified in Hematology and Medical Oncology; he practices at the O'Neal Comprehensive Cancer Center at UAB Medicine. He is an assistant professor at UAB (The University of Alabama at Birmingham).
Pediatric Blastomas & Extracranial Germ Cell Tumors
Elaine fan.jpeg
Elaine M. Fan, MD, MS
Wichita, KS, USA
Dr. Fan is an Assistant Professor of Pediatrics at the University of Kansas and practices at Wesley Medical Center. She is particularly interested in applying clinical informatics to improve clinical workflow efficiency, enhance provider and patient experience and, ultimately, improve health outcomes in pediatrics and pediatric hematology-oncology. Dr. Fan is board-certified in Pediatrics and board-eligible in Pediatric Hematology-Oncology.
Pediatric Leukemia & Lymphoma
Noyd.png
David Noyd, MD, MPH
University of Washington
Seattle, WA, USA
Dr. Noyd is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at Seattle Children's Hospital. He is an Assistant Professor of Pediatrics at the University of Washington.
Pediatric Neuro-Oncology & Solid Tumors
Nwood.jpeg
Nicole M. Wood, DO
University of Missouri
Kansas City, MO, USA

LinkedIn
Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at Children's Mercy Kansas City. She is an Assistant Professor of Pediatrics at the University of Missouri.
Transplant
Hilal.jpg
Talal Hilal, MD
Mayo Clinic
Phoenix, AZ, USA
Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at Mayo Clinic Arizona. He is an assistant professor at the Mayo Clinic.
Classical Hematology
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Vanderbilt University
Nashville, TN, USA
Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an Assistant Professor of Medicine (Hematology/Oncology)
Clinical Pharmacology
Fitts.jpeg
Austin Fitts, PharmD
National Cancer Institute
Silver Springs, MD, USA

LinkedIn
Dr. Fitts is a Postdoctoral Fellow at the National Cancer Institute.
Living Systematic Reviews
Riaz.jpeg
Irbaz Bin Riaz, MD, PhD, MS
Mayo Clinic
Phoenix, AZ, USA
Dr. Riaz is board certified in Internal Medicine and Medical Oncology; he is an Assistant Professor of Medicine at Mayo Clinic, Arizona.

Page Editors

COI Disclosures

Please see our conflict of interest page for more details. Disclosures here are for COI within 24 months of the date of disclosure unless otherwise noted.

Name Research funding (to institution) Other (honoraria, travel support, significant ownership interests, etc.) Date of disclosure
Jon Arnason Nothing to disclose Speaker: Bristol-Myers Squibb 2023-06-28
Brianna Bakow Nothing to disclose Nothing to disclose 2023-08-27
Danielle S. Bitterman Nothing to disclose Nothing to disclose 2023-08-03
Alaina J. Brown NIH Nothing to disclose 2022-08-03
Elizabeth Buchbinder NIH; Clinical trial support from Eli Lilly, Novartis, Checkmate Pharmaceuticals, Genentech/Roche, and Bristol-Myers Squibb. Consulting as an advisory board member for Novartis, Instil Bio, Nektar, Xilio Therapeutics, Sanofi, Merck, Iovance Biotherapeutics; Employment (family member): Alexion Pharmaceuticals, Takeda. 2023-08-03
Jennifer H. Choe Institutional research funding: Alx oncology, Merck Sharp & Dohme, Arcus Biosciences Advisory Board and consulting: Eisai, Exelixis, Merck Sharp & Dohme, Coherus Biosciences 2023-09-29
Andrew Cowan Abbvie, Nektar, Harpoon, Janssen, Adaptive, Sanofi, BMS, Celgene Consultancy: Abbvie, BMS, Secura Bio, EUSA, GSK 2022-04-26
Elizabeth J. Davis Trial funding: Karyopharm, Bristol Myers Squibb, Incyte, Actuate, InhibRx, Top Alliance BioSciences, Genentech, Five Prime Therapeutics Consulting/Advisory Board: Deciphera, Aadi
Honoraria: MJH Life Sciences
Speakers' Bureau: Physicians' Education Resource
2023-01-03
Bhagirathbhai Dholaria Research funding: Janssen, Angiocrine, Pfizer, Poseida, MEI, Orcabio, Wugen, Allovir, NCI, Atara, Gilead, Molecular templates, BMS, AstraZeneca, Adicet Consulting/Advisory Board: Janssen, Pluri Biotech, Boxer Capital; Consultation/travel funds: Ellipsis pharma, Lumanity, Autolus, Acrotech, ADC therapeutics 2023-09-09
Elaine Fan Nothing to disclose Consulting: Westat 2023-09-09
H. Deepika Fernandes Nothing to disclose Nothing to disclose 2023-06-28
Austin Fitts Nothing to disclose Consulting: Westat 2023-01-03
Teja Ganta Nothing to disclose Other: Epic Systems, Analog Devices 2023-09-04
Michael J. Glover Nothing to disclose Nothing to disclose 2023-04-15
Gaurav Goyal NIH/NCI Consultancy: 2nd.MD; Royalties: UpToDate Inc; Advisory Board: Opna Bio LLC, Seagen 2023-09-10
Laura Graham Nothing to disclose Nothing to disclose 2023-09-11
Matthew Hadfield Nothing to disclose Nothing to disclose 2023-08-07
Talal Hilal NIH/NCI Nothing to disclose 2023-09-11
C. Beau Hilton Nothing to disclose Nothing to disclose 2023-10-03
Ali R. Khaki Janssen, 23andMe Consulting/Advisory Board: Seagen/Astellas
Travel: BCAN; SABCS
Honoraria: Onclive CME
2023-09-01
Ashwin Kishtagari Nothing to disclose Consulting/Advisory Board: CTI BioPharma 2023-08-03
Shalin Kothari Nothing to disclose Nothing to disclose 2023-08-10
Amit Kulkarni Research Funding to Institution: Astra Zeneca Consulting/Advisory Board: Genentech, Exelixis; Stock and Other Ownership Interests: Fate Therapeutics, Merck, Exact Sciences, Gilead Sciences, Mirati Therapeutics, Novavax. 2023-08-03
Mary L. Kwok BeiGene Nothing to disclose 2023-06-28
Wayne H. Liang Nothing to disclose Consulting/Advisory Board: Westat 2021-11-10
Maryam Lustberg Nothing to disclose Consulting/Advisory Board: Pfizer, Gilead, Novartis, Eli Lilly, AstraZeneca 2023-07-04
Mark P. Lythgoe Nothing to disclose Nothing to disclose 2023-10-29
Emily A. Mann Nothing to disclose Nothing to disclose 2023-08-30
Eric Marks Research funding: Merck Consulting/Advisory Board: Sermo, Medscape, Brand Institute, M3 2023-06-28
Mary Mesnard Nothing to disclose Nothing to disclose 2023-08-03
Sanjay R. Mohan Research funding: NCCN, Ichnos, Incyte, Kartos, Karyopharm, Taiho Nothing to disclose 2023-08-24
Francesca Montanari Nothing to disclose Nothing to disclose 2023-06-29
Seema Nagpal Trial funding: Agios, PharmAbcine, Insightec, Berg, Inovio Consulting/Advisory Board: EnClear, SeaGen, Novocure Steering Committee, Nurix, Biocept Steering Committee; Guidelines: NCCN CNS committee, ARS-AUC CNS committee, ASTRO Brain metastases guideline committee 2022-04-22
Ryan Nguyen Exelixis (research funding to institution) Genomeweb (honoraria), Merck (speaker's bureau) 2023-09-16
David Noyd Nothing to disclose Consulting/Advisory Board: Westat 2023-09-11
Irbaz Bin Riaz NIH/NCI Nothing to disclose 2023-08-10
Michael K. Rooney Nothing to disclose Nothing to disclose 2023-09-13
Samuel R. Rubinstein Nothing to disclose Consulting/Advisory Board: Janssen, Sanofi, LAVA therapeutics, EUSA pharma, and Roche Diagnostics 2022-09-10
Martin Schoen St. Louis Veterans Affairs Medical Center, Congressionally Directed Medical Research Program Consulting/Advisory Board: Doximity, Pfizer 2023-08-11
Sanjai Sharma Nothing to disclose Nothing to disclose 2023-09-11
Eric K. Singhi Nothing to disclose Consulting/Advisory Board: AstraZeneca 2023-08-10
Benjamin F. Tillman Nothing to disclose Nothing to disclose 2023-01-29
Jeremy L. Warner AACR; NIH; Brown Physicians Incorporated Travel: AACR; ASCO
Ownership: HemOnc.org
Consulting/Advisory Board: Westat, MelaxTech
Editorship: ASCO
2022-12-29
Nicole M. Wood Nothing to disclose Consulting/Advisory Board: Westat 2023-08-07
Peter C. Yang Nothing to disclose Ownership: HemOnc.org
Stock: Merck, Pfizer
2023-10-12
Travis Zack Nothing to disclose Nothing to disclose 2023-09-05
Marjorie Zauderer Memorial Sloan Kettering receives research funding from the Department of Defense, the National Institutes of Health, Precog, GlaxoSmithKline, Epizyme, Polaris, Sellas Life Sciences, Bristol Myers Squibb, Millenium/Takeda, Curis, and Atara for research conducted by Dr. Zauderer. In the last 3 years, Dr. Zauderer has received consulting fees from Curis, Ikena, Takeda, GlaxoSmithKline, Aldeyra Therapeutics, Novocure, and Atara and honoraria for CME content from PER, Medscape, Research to Practice, Medical Learning Institute and OncLive. Dr. Zauderer serves as Chair of the Board of Directors of the Mesothelioma Applied Research Foundation, uncompensated. 2023-08-08
Leyre Zubiri Nothing to disclose Honoraria: Merck 2022-08-22